Antimicrobials Overview_ Batch 31

44
Overview of antimicrobial agents Dr. Vasudha Devi

Transcript of Antimicrobials Overview_ Batch 31

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 1/44

Overview of antimicrobial agents

Dr. Vasudha Devi

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 2/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 3/44

Tips- basics

F. All protein synthesis inhibitors are staticaccept aminoglycosides

Combination of protein synthesis inhibitorsmay be cidal ( cotrimoxazole)G. If a prototype drug act only on G-ve organism,the subsequent drugs developed in that class act

on G +ve also and Vice versa…example,ciprofloxacin acts mainly on G –ve organisms,where as other drugs ( newer) act on G +ve also.

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 4/44

• Drugs having low penetrability, will not act onintracellular organisms ( like beta lactams have noaction on intracellular pathogens like ligonella,chlamydia)

• Some tables and graphs are very informative and helpyou to understand this topic…Selected ones are used inthis overview and underlined words are veryimportant.

• You are not required to remember the wholespectrum. Instead, identify the common uses (infections) of a particular drug and rememberorganism causing that infection

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 5/44

Clinically important bacteriaGram +ve

Cocci

StaphylococcusS. aureus

S. epidermidis

StreptococcusS. pyogenes

S. viridansS. Pneumoniae

EnterococcusE. faecalis

Bacilli

ClostridiumC. tetani

C. perfringensC.difficile

C. botulinum

Corynebacterim diphtheriae

Listeria monocytogenes

Bacillus anthracis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 6/44

Gram -veCocci

Neisseria N.gonorrheaeN.menigitidis

BacilliEnterobacteriaceae

Escherichia coliSalmonella typhiShigella

KlebsiellaProteusHelicobacter pyloriColiforms

Pseudomonas aeruginosa

Ligionella pneumophiliaCamphylobacterVibrio choleraeHaemophilus influenzaeBordetella pertussis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 7/44

others

• Spirochetes

Treponema pallidum

Leptospira• Reckettsia• Chlamydiae

(intracellular)Chlamydia trachomatis

Chlamydia pneumoniae

• Mycoplasma pneumoniae( lack cell wall)

• Pnemocystis carini

(Pneumocystis jiroveci)

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 8/44

Diseases caused – S. aureus: abscess (furuncle, carbuncle),

endocarditis, pneumonia – S. epidermidis : skin flora; Biofilm formation on

plastic devices infectionEndocarditis

– S. pyogenes: Pharyngitis, sinusitis, otitis media,rheumatic fever, glomerulonephritis, septicemia

S. viridans: endocarditis, septicemia – S. Pneumoniae: pneumonia, meningitis, sinusitis – E. faecalis: endocarditis, UTI

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 9/44

C. tetani: tetanus

C. perfringens: gas gangreneC.difficile: pseudomembranous colitisC. botulinum: food poisoning

All are anaerobic

Corynebacterium diphtheriae (aerobic):Diphtheria

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 10/44

Escherichia coli: UTI, dysenterySalmonella typhi: typhoid, food poisoning

Shigella: gastroenteritis, dysenteryKlebsiella: UTIProteus: UTIHelicobacter pylori: peptic ulcerColiformsPseudomonas aeruginosa: UTI, pneumonia, burninfection

Vibrio cholerae: CholeraHemophilous influenzae: sinusitis, bronchitis,pneumonia, meningitis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 11/44

Treponema pallidum: syphilis

Leptospira : leptospirosisChlamydia trachomatis: sexually transmitted disease(lymphogranuloma venereum)

• Pneumocystitis carnii: pneumonia in AIDS,lung infection in immunocompromised

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 12/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 13/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 14/44

Bactericidal• Penicillins• Cephalosporins• Carbapenems• Monobactams• Vancomycin• Quinolones• Aminoglycosides• Bacitracin• Colistin• Polymyxin B• Cotrimoxazole

Bacteriostatic• Tetracyclines• Sulfonamide• Trimethoprim• Macrolides• Chloramphenicol• Clinidamycin• Lincomycin• Nitrofurantoin•

Linezolid• Telithromycin

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 15/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 16/44

Betalactams

Inhibition of transpeptidase↓

Accumulation of precursor cell wall units

Formation of an imperfect cell wall↓

Activation of cells autolytic enzymes↑ osmotic drive

↓ Cell lysis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 17/44

Betalactams

• Have different uses• No action on those lack cell wall (mycoplasma)•

No action on intracellular pathogens(ligonella, chlamydia): cannot cross

ll b h bl (

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 18/44

Penicillins: remember this table (not routesfor all), you can write uses using this

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 19/44

Narrow spectrum penicillins

• Pen V and GSpectrum: all G +ve cocci and bacilli

SpirochetesNo action on staph (produce β lactamases)No action on G –ve

• β lactamase resistant penicillinsSpectrum: Like Pen G + Staph

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 20/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 21/44

Amoxicillin+ clavulanic acid:• useful in β lactamase producing organisms:

Staph, Srep pneumonia, H.influenzae,Neisseria, E.coli, proteus, Klebsiella

• But not in MRSA

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 22/44

Ureidopenicillins and carboxypenicillins:Spectrum: same as aminopenicillins +

pseudomonasUse: UTI, septicemia, burn infection caused by

pseudomonas; in combination withgentamicin

Resistance to cloxacillin/nafcillin: MRSAdue to altered PBP

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 23/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 24/44

Cephalosporins

• Not active on enterococcus, MRSA, G +ve bacilli• 1st generation: X BBB

Excreted in kidneySensitive to β lactamase

degradationCocci > Bacilli ( G – ve)

Cefazolin: penetrates tissues surgical prophylaxis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 25/44

2nd generation

• Cefuroxime cross BBB• Cefoxitin

G –ve cocci and bacilli (like Amoxicillin +clavulanic) > G +ve cocci+

Anaerobes (Lower abdominal and gynecologicalinfection)Not used much

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 26/44

3rd generation ( V. V. Imp)

• Ceftriaxone, cefitaxime, cefixime• G –ve cocci and bacilli, anaerobes > G +ve

cocci ( less than 1 st generation)• All cross BBB• Highly resistant to β lactamase producing G –

ve bacteria

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 27/44

4 th generation

• Spectrum: same as 3 rd generation for G –vecocci and bacilli; but highly activeNot on anaerobes

• Used in infection resistant to 3 rd generation hospital acquired infection

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 28/44

Monobactams

• Betalactam• Spectrum: like aminoglycosides•

Used in patients with renal impairment whereAMG cannot be used• No cross sensitivity with other betalactams

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 29/44

Carbapenems

• Spectrum: G-ve bacilli, G +ve and anaerobes

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 30/44

Glycopeptides: vancomycin,teicoplanin

• Large molecules: do not penetrate into G –vecells used in G +ve infections

• Act at an earlier stage than beta-lactams: notused in combination

• iv: used in MRSA, patients allergic to beta-lactams, Orally: in Clostridium difficileinfection

• With AMG for enterococcal endocarditis

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 31/44

Drugs used in MRSA

• Vancomycin• Teicoplanin•

Daptomycin + gentamicin• Linezolid• Quinupristin + dalfopristin

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 32/44

Protein synthesis inhibitors

• All are bateriostaticACCEPT aminoglycosides

• May become cidal when used in combination:cotrimoxazole, quinupristine + dalfopristine

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 33/44

• Just forunderstanding. Do notmug up.

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 34/44

Aminoglycosides

• Polar: Given iv or im• Do not cross BBB• Used in mainly in serious G –ve infections• Remember general properties of this group

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 35/44

• Just forunderstanding. Donot mugup.

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 36/44

Tetracyclines• Are active against wide variety of bacteria, but their

use is restricted due to widespread resistance• Given orally• Absorption: complete only for doxycycline and

minocycline: other drugs remain in the intestine - problems

• Well distributed and penetrates host cells to reachintracellular organisms

• Used in infection caused by mycoplasma, chlamydiae,

rickettsiae• Avoid them in pregnancy and in children < 8 years of

age

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 37/44

Macrolides

Erythromycin• Well distributed, penetrates host ells• Spectrum: like ampicillin Aerobic

microorganisms causing respiratory tractinfection, mycoplasma, chlamydia

• Relatively free of serious toxic effectsAzithromycin

Spectrum: same as erythromycin + more activityagainst H. influenza and intracellular organisms

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 38/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 39/44

Streptogramins

• Combination: Quinupristin + dalfopristin• Bactericidal• In Serious infection: MRSA

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 40/44

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 41/44

Cotrimoxazole• Sulfamethoxazole + trimethoprim• Widely distributed, reach intracellular organisms• Concentrated in prostatic fluid•

Folic acid pathway inside the cell• Drug need to reach the cytoplasm• G +ve has thick cell wall difficult to cross• Hence active on G –ve organisms: UTI, typhoid,

Diarrhea due to shigella & salmonella• Mainly used in G-ve infections, chlamydia,

pneumocystitis carinii pneumonia

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 42/44

Quinolones

• Many generations available with variedactivity

• Act by inhibiting DNA replication henceneed to enter the cell

• Entry is easy with G –ve (cocci and bacilli)through porin channels ( no cell wall)

• Low PPB good penetration to tissuespenetrates intracellular organisms

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 43/44

• Justforunderstanding. Donot

mugup.

8/9/2019 Antimicrobials Overview_ Batch 31

http://slidepdf.com/reader/full/antimicrobials-overview-batch-31 44/44

ALL THE BEST